Prescriber

Future Prescriber

Future Prescriber provides information on new drugs from early development through to launch. It also covers significant developments with drugs that are currently available and discusses the potential impact of prescribing policy changes. Future Prescriber is designed for decision makers in Trusts and Strategic Health Authorities and also lead-prescribing members of PCTs, LHCCs and LHGs. Future Prescriber meets the growing information needs of decision makers and planners in the NHS and ensures that these decision makers are well informed and prepared for the changes brought about by important new product initiatives. Access to all content is free to healthcare professionals following registration.

 

Latest News

Nycomed have submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMEA) for roflumilast (Daxas) as a once-daily...

A double-blind, placebo-controlled, phase IIa study has failed to demonstrate that Cytos Biotechnology’s hypertension vaccine, CYT006-AngQb, is...

A recent phase III study has found that patients with primary hypercholesterolaemia or mixed dyslipidaemia experienced reduced LDL-C of almost 48%,...

DATES FOR YOUR DIARY

thumbnail image: title

Search the Site

Search

Site Adverts